| Net Cash Provided by (Used in) Operating Activities |
$1,539 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
9,888,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
64,990,254 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$1,931 |
USD |
49% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$561,538 |
USD |
2% |
Q4 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
$0 |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$561,538 |
USD |
2% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
1,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
5,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$2,418,816 |
USD |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
1,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q4 2024 |
FY 2024 |
| Interest Expense |
$0 |
USD |
|
Q1 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |